about
Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.Critical care services and 2009 H1N1 influenza in Australia and New Zealand.Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trialA randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome.Age of red blood cells and mortality in the critically ill.Dynamic lactate indices as predictors of outcome in critically ill patients.Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemiaHypercapnia and acidosis in sepsis: a double-edged sword?Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice.Erythropoietin as a novel brain and kidney protective agent.Hypoxaemic rescue therapies in acute respiratory distress syndrome: Why, when, what and which one?Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis.Erythropoiesis-stimulating Agents in Critically Ill Trauma Patients: A Systematic Review and Meta-analysis.Venous thromboembolic events in critically ill traumatic brain injury patients.A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients.Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan.Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries.Targeted therapeutic mild hypercapnia after cardiac arrest.Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.Infection-induced lung injury is worsened after renal buffering of hypercapnic acidosis.Comment on Rishu et al. Time required to initiate outbreak and pandemic observational research.Prospective observational study of postoperative complications after percutaneous dilatational or surgical tracheostomy in critically ill patients.The NAPRESSIM trial: the use of low-dose, prophylactic naloxone infusion to prevent respiratory depression with intrathecally administered morphine in elective hepatobiliary surgery: a study protocol and statistical analysis plan for a randomised coCause and timing of death and sub-group differential effects of erythropoietin in the EPO-TBI study.Protocol for a multicentre randomised controlled trial of early and sustained prophylactic hypothermia in the management of traumatic brain injury.Erythropoietin for traumatic brain injury.Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study.Transfusion practice and guidelines in Australian and New Zealand intensive care units.Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis.Bending the Pandemic Curve: Improving Decision-Making With Clinical Research.The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke.Open source clinical science for emerging infectionsInhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial.Priority Needs for Conducting Pandemic-Relevant Clinical Research With Children in Europe: A Consensus Study With Pediatric Clinician-ResearchersPathophysiology of severe traumatic brain injuryA Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care Patients with Severe SepsisWho Says There Is No “I” in Team? Achieving Individual Success in Collaborative Clinical Research in Critical Care
P50
Q27335056-12312FD7-DA48-4015-A550-0AD8DD69065BQ30381497-8016A65A-DD19-4ED7-A67F-FF6B27CA6431Q35079125-79FD4003-FC90-4C2E-8919-997699B4DEBEQ35558269-E1023618-53EA-407D-A418-AAE0F31EC69BQ35559622-2552EFA1-0D46-4EE3-BDE6-A0A54716088FQ35908264-847F257B-84D6-4E11-AD12-9B2534503D5CQ36928251-472AEAF8-F86A-47EF-9CD7-276632C9A7F5Q37672901-8E6B4B6F-51F7-4DB5-AA93-4539C04E9508Q37753956-5810DED7-0BC3-43EC-B608-90EC9E98FA5EQ37889877-B17AF3A1-3386-4A37-9966-57119D774D94Q38069316-790F742D-64DE-4263-ADDD-A9E9F0E24C41Q38673765-5FE0167A-8DEF-459E-93AC-3681408BB344Q38762848-A4ADE346-6E37-41FB-9AA6-ADAAC4243EB9Q38806267-B4DD3E79-D9EA-4784-A660-AA199BE600ACQ39061409-DFA87230-FF8C-42F5-B337-978D20197773Q39687181-36D45BC1-F1E2-42E3-9EBC-8B36D40B0EA5Q40447654-A77F67BE-F21F-422F-84A1-B83ACB4956A2Q41641714-458B1615-EC28-4022-9A46-85F40E06275DQ41928108-8F91B8EB-FE9B-4B7A-9C26-9A309B28520DQ42339639-71298835-295E-4C14-8048-D6B253A026B4Q43144988-FD71EC7C-B30A-49C7-AD15-24E445CC5989Q43272791-0272CE3F-9E55-499D-A66E-F014CB7910F1Q43679912-B590965F-91BF-48C2-B97B-14AB611C8C90Q46013721-6901566C-8E3C-40FC-9C54-01082934E0FBQ47217157-315BD005-0836-4432-98C8-F82AB660F4EAQ47242904-740BF322-7306-4ACE-9CC8-4A27000C3C11Q48157627-A8BC678F-71CC-4222-91F1-2F01C993B89FQ48459809-72F244AC-182C-4E60-9010-373B7C359A02Q48622129-3EB63614-EE49-49FB-8ED0-6D2E6B2932AAQ50578804-B99958BB-9601-4E37-8658-B3861B45F6B5Q52662137-736B9ACD-055B-43A0-A415-C1BC00118AFEQ52688368-9B0C4FC1-BC04-4A4D-8731-196044E1B679Q53110007-024509FD-8356-4F35-BB85-97FAE90FDE57Q53678328-A6BB0562-D09D-466B-8F9B-E8EB74BAE0EAQ53854458-D2A94A21-C3CC-4E97-848B-BD3AB4377DC4Q54226581-FFB978DE-A6F2-4CA5-9384-B96E527B501DQ57093593-59ECC06E-F170-4EF6-93A8-45819EF1A98AQ57142358-2CCBE799-9819-4473-8B6E-4772FEC26E80Q59523516-CF4420C7-3B51-4D7D-AF1D-89DAA8765464Q60660411-20E0DBAA-8678-442C-9634-B1E243156E7D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alistair Nichol
@ast
Alistair Nichol
@en
Alistair Nichol
@es
Alistair Nichol
@nl
type
label
Alistair Nichol
@ast
Alistair Nichol
@en
Alistair Nichol
@es
Alistair Nichol
@nl
prefLabel
Alistair Nichol
@ast
Alistair Nichol
@en
Alistair Nichol
@es
Alistair Nichol
@nl
P106
P21
P31
P496
0000-0002-4689-1238